BMO Capital: 'Centessa Pharmaceuticals (CNTA) Remains One of Our Favorite Names in 2025' Mar 25, 2025 09:01AM
BMO Capital Highlights Favorite Names for 2025 in Biotech Dec 20, 2024 12:46PM
BMO Capital Reiterates Outperform Rating on Centessa Pharmaceuticals (CNTA) Sep 27, 2024 07:15AM
Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares Sep 12, 2024 10:34PM
Centessa Pharmaceuticals (CNTA) Announces $150M ADS Offering Sep 11, 2024 04:05PM


Sep 11, 2024 04:04PM Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
Sep 10, 2024 07:15AM BMO Capital Reiterates Outperform Rating on Centessa Pharmaceuticals (CNTA)
Sep 9, 2024 08:13AM Centessa Pharmaceuticals (CNTA) PT Raised to $20 at BMO Capital
Aug 14, 2024 10:06AM BMO Capital Reiterates Outperform Rating on Centessa Pharmaceuticals (CNTA)
Apr 23, 2024 09:40PM Centessa Pharmaceuticals (CNTA) Announces Pricing of $100 Million Public Offering of American Depositary Shares
Apr 23, 2024 09:36PM Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares
Apr 23, 2024 04:18PM Centessa Pharmaceuticals (CNTA) Announces $100 Million Proposed Public Offering of American Depositary Shares
Apr 23, 2024 04:17PM Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
Jun 16, 2022 04:15PM UPDATE: BMO Capital Starts Centessa Pharmaceuticals (CNTA) at Outperform